Evidence map›Paper›PMID 22195555›Full record

ArticleChemistry & biology2011

Selective overproduction of the proteasome inhibitor salinosporamide A via precursor pathway regulation.

Anna Lechner, Alessandra S Eustáquio, Tobias A M Gulder, Mathias Hafner, Bradley S Moore

Abstract read
In one paragraph

Article in Chemistry & biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  12. Challenges and triumphs to genomics-based natural product discovery.Journal of industrial microbiology & biotechnology · 2014
    Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anna LechnerScripps Institution of Oceanography, University of California at San Diego, La Jolla, CA 92093-0204, USA.
Alessandra S Eustáquio
Tobias A M Gulder
Mathias Hafner
Bradley S Moore
Scripps Institution of Oceanography · USTechnische Hochschule Mannheim · DE

Funding

Salinosporamide Biosynthesis and EngineeringR01CA127622 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, BRADLEY S · 2007 to 2016
$2.8M
NCI NIH HHS CA127622NCI NIH HHS R01 CA127622
6 · The paper itself

Abstract

The chlorinated natural product salinosporamide A is a potent 20S proteasome inhibitor currently in clinical trials as an anticancer agent. To deepen our understanding of salinosporamide biosynthesis, we investigated the function of a LuxR-type pathway-specific regulatory gene, salR2, and observed a selective effect on the production of salinosporamide A over its less active aliphatic analogs. SalR2 specifically activates genes involved in the biosynthesis of the halogenated precursor chloroethylmalonyl-CoA, which is a dedicated precursor of salinosporamide A. Specifically, SalR2 activates transcription of two divergent operons-one of which contains the unique S-adenosyl-L-methionine-dependent chlorinase encoding gene salL. By applying this knowledge to rational engineering, we were able to selectively double salinosporamide A production. This study exemplifies the specialized regulation of a polyketide precursor pathway and its application to the selective overproduction of a specific natural product congener.

Indexed as

Proteasome InhibitorsAmino Acid SequenceBacterial ProteinsEnzyme InhibitorsLactonesMicromonosporaceaeMolecular Sequence DataProteasome Endopeptidase ComplexProtein BindingPyrrolesRecombinant ProteinsBacterial ProteinsEnzyme InhibitorsLactonesmarizomibProteasome Endopeptidase ComplexProteasome InhibitorsPyrrolesRecombinant Proteins

Identifiers

PMID22195555
PMCPMC3246214
OpenAlexW2059756274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.